Literature DB >> 11857363

A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997.

Philippe Autier1, Ferid Shannoun, Astrid Scharpantgen, Christiane Lux, Carlo Back, Gianluca Severi, Simone Steil, Danielle Hansen-Koenig.   

Abstract

The national breast cancer screening programme in Luxembourg, the Mammography Programme (MP), was launched in 1992. Its primary goal was to set up an organised breast cancer screening with biennial invitation-reinvitation of women 50-64 years, 2-view mammography, technical quality assurance, double-reading procedures and close monitoring of performance. In 1994, the decision was taken by health authorities to only reimburse screening mammograms done within the MP. We evaluated the performance of 3 screening rounds that took place in 1992-1997. In 1992, 4,815 women had opportunistic screening and 4,790 attended the MP. In 1997, 861 women had opportunistic screening and 8,603 attended the MP. In 1997, the participation rate in the MP reached 50%. The referral rate in the MP was 10% for initial screening and 5% for subsequent screening. Echographic examinations accounted for 71% of referrals. Per 1,000 screened women, biopsy and cancer rates were 18.0 and 8.0 for initial screening and 10.3 and 5.8 for subsequent screening. Twenty-one percent of the breast cancers diagnosed in screened women were interval cancers. The age-adjusted proportion of tumours >20 mm was 56.1% before 1992, 45.1% for women not (yet) screened by the MP, 27.0% for interval cancers, 26.6% for initial screening and 12.0% for subsequent screenings. Tumour size distribution was similar to that observed in the Dutch Breast Cancer Screening Programme, 1990-1993, except that in the latter programme, no difference was observed between initial and subsequent screening. The Luxembourg experience shows that in a liberal health care system, a policy of organising the screening process by reimbursing only those mammograms done within the context of the organised screening programme can drastically reduce opportunistic screening. Further efforts in the Mammography Programme will aim at increasing participation and look at ways to decrease referrals to echography. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11857363     DOI: 10.1002/ijc.10161

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  International variation in screening mammography interpretations in community-based programs.

Authors:  Joann G Elmore; Connie Y Nakano; Thomas D Koepsell; Laurel M Desnick; Carl J D'Orsi; David F Ransohoff
Journal:  J Natl Cancer Inst       Date:  2003-09-17       Impact factor: 13.506

2.  Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme.

Authors:  Ondrej Majek; Jan Danes; Miroslava Skovajsova; Helena Bartonkova; Lucie Buresova; Daniel Klimes; Petr Brabec; Pavel Kozeny; Ladislav Dusek
Journal:  BMC Public Health       Date:  2011-05-10       Impact factor: 3.295

Review 3.  Breast Cancer Screening Programmes across the WHO European Region: Differences among Countries Based on National Income Level.

Authors:  Emma Altobelli; Leonardo Rapacchietta; Paolo Matteo Angeletti; Luca Barbante; Filippo Valerio Profeta; Roberto Fagnano
Journal:  Int J Environ Res Public Health       Date:  2017-04-23       Impact factor: 3.390

4.  Mapping Variation in Breast Cancer Screening: Where to Intervene?

Authors:  Cindy M Padilla; François Painblanc; Patricia Soler-Michel; Veronica M Vieira
Journal:  Int J Environ Res Public Health       Date:  2019-06-27       Impact factor: 3.390

5.  Mammography-based screening program: preliminary results from a first 2-year round in a Brazilian region using mobile and fixed units.

Authors:  Raphael Luiz Haikel; Edmundo Carvalho Mauad; Thiago Buosi Silva; Jacó Saraiva de Castro Mattos; Luciano Fernandes Chala; Adhemar Longatto-Filho; Nestor de Barros
Journal:  BMC Womens Health       Date:  2012-10-02       Impact factor: 2.809

6.  Breast cancer in European Union: an update of screening programmes as of March 2014 (review).

Authors:  E Altobelli; A Lattanzi
Journal:  Int J Oncol       Date:  2014-09-01       Impact factor: 5.650

7.  A national cross-sectional study of adherence to timely mammography use in Malta.

Authors:  Danika Marmarà; Vincent Marmarà; Gill Hubbard
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.